https://doi.org/10.4081/hls.2022.10251

Comparative efficacy of interferential therapy, bronchodilators, and body positioning on asthma control and quality of life of patients with bronchial asthma: A study protocol

Vol. 10 No. 1 (2022)
Submitted: 25 October 2021
Accepted: 11 January 2022
Published: 20 January 2022
IFT, asthma, PFT, ACT, AQLQ
Abstract Views: 4713
PDF: 433
HTML: 100
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Eniola Awolola Oladejo
220068603@stu.ukzn.ac.za
https://orcid.org/0000-0002-9185-7565
Department of Physiotherapy, College of Health Sciences, University of KwaZulu- Natal, Durban, South Africa.
Sonill Maharaj Sooknunan
https://orcid.org/0000-0001-8288-6105
Department of Physiotherapy, College of Health Sciences, University of KwaZulu- Natal, Durban, South Africa.

Interferential Therapy (IFT) is the application of two medium frequency currents to the skin to stimulate and activate different systems in the body using specific frequencies and frequency ranges. The aim in applying IFT is to reduce myalgia in the chest and upper back, reduce muscular fatigue, and induce mucus expectoration. This study is designed to test the efficacy of IFT in reducing the symptoms frequently experienced by patients with bronchial asthma. Forty-eight (48) patients aged 18 and above with bronchial asthma attending the respiratory clinic at the Lagos State University Teaching Hospital, Ikeja (LASUTH) will be assessed for eligibility. The study design will be a double-blinded, randomized control trial with four intervention groups and four parallel placebo control groups. IFT will be administered as an intervention to patients on short and longacting bronchodilators in an assigned fundamental body position for 20 minutes. Six continuous outcome variables at different points will be utilized as outcome measures. A baseline Pulmonary Function Test (PFT) will be conducted on entry into the study while quality of life and asthma control will be evaluated every two (2) weeks during the study. Data obtained will be analyzed using descriptive and inferential statistics of repeated ANOVA; P<0.05. The study outcome will compare the efficacy of IFT on bronchial asthma, identify its effect in different body positions, and compare the relationship between its application and the bronchodilator medication frequently used by the patients.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Masoli M, Fabian D, Holt S, Beasley R. Global Initiative for Asthma (GINA) Program. The global burden of asthma: Executive summary of the GINA Dissemination Committee report. Allergy 2004:59:469–478.
Desalu OO, Oluboyo OP, Salami AK. The prevalence of bronchial asthma among adults in Ilorin, Nigeria. Afr J Med Med Sci 2009:38:149–54.
Ibe CC, Ele UP. Prevalence of bronchial asthma among adolescents in Anambra State, Nigeria. Nigeria J Int Med 2002:5:23–6.
Erhabor GE, Agbroko S, Bamigboye P, Awopeju OF. Prevalence of asthma symptoms among university students 15 to 35 years of age in Obafemi Awolowo University, Ile-Ife, Osun State. J Asthma 2006:43:161–4.
Oni AO, Erhabor GE, Egbagbe EE. The prevalence, management and burden of asthma - a Nigerian study. Iran J Allergy Asthma Immunol 2010;9:35-41.
National Asthma Education and Prevention Program, Third Expert Panel on the Diagnosis and Management of Asthma. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Bethesda (MD): National Heart, Lung, and Blood Institute (US); 2007 Aug. Available from: https://www.ncbi.nlm.nih.gov/books/NBK7232/
Oni AO, Erhabor GE, Egbagbe EE. The prevalence, management and burden of asthma-A Nigerian study. Iran J Allergy Asthma Immunol 2010:1:35-41.
Cazzola M, Page CP, Calzetta L, Matera MG. Pharmacology and therapeutics of bronchodilators. Pharmacology Rev 2012:3:450-504.
GINA. Global Initiative for Asthma. Global strategy for asthma management and prevention, 2021. Available from: www.ginasthma.org
Boros PW and Martusewicz-Boros MM. Reversibility of airway obstruction vs bronchodilatation: do we speak the same language? COPD 2012;9:213-215.
Chung KF, Wenzel SE, Brozek JL. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014;43:343-73.
Katz S, Arish N, Rokach A. The effect of body position on pulmonary function: a systematic review. BMC Pulm Med 2018;18:159.
Emberson W. Asthma interferential therapy and chartered physiotherapy. Positive Helath Online 1999;36.
Shuto H, Nakagami K, Suzuki H, Noguchi E. Low-frequency interference in bronchial asthma. Jap J Allergol 1986;35:12:1170-80.
Goats GC. Interferential current therapy. Br J Sports Med 1990:24:87-92.
McManus FJ, Ward AR, Robertson VJ. The analgesic effects of interferential therapy on two experimental pain models: cold and mechanically induced pain. Physiotherapy 2006:92:95-102.
Ozcan J, Ward AR, Robertson VJ. A comparison of true and premodulated interferential currents. Arch Phys Med Rehabil 2004;85:409-415.
Juniper EF, Guyatt GH, Ferrie PJ. Measuring quality of life in asthma. Am Rev Respir Dis 1993;147:832-8.
Quanjer PH, Enright PL, Miller MR. Open letter: the need to change the method for defi ning mild airway obstruction. Prim Care Respir J 2010:19:288–91.
Suresh K. An overview of randomization techniques: An unbiased assessment of outcome in clinical research. J Hum Reprod Sci 2011;4:8-11.
Masekela R, Zurba L, Gray D. Dealing with access to spirometry in Africa: a commentary on challenges and solutions. Int J Environ Res Public Health 2019;16:62.
Davis V. Management of asthma. Dynamic Chiropractic J 1992;10.
Wallin A, Sandstrom T, Rosenhall L, et al. Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma. Thorax 1993;48:611-4.
Basheti IA, Natsheh AI, Ammari WG. Education on correct inhaler technique in pharmacy schools: Barriers and needs. Tropical J Pharm Res 2015;14:715-22.
Nathan RA, Sorkness CA, Kosinski M. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004;113:59-65.
nSpire. KoKoPFT. 2020. Accessed 04/02/21. Available from: https://www.kokopft.com/
Feng JF, Ding GR, Xie YZ. Efficacy of budesonide/formoterol and tiotropium combination for the treatment of Chinese patients with chronic obstructive pulmonary disease. Medicine (Baltimore) 2018; 97: e10841.
Hanania NA, Sethi S, Koltun A. Long-term safety and efficacy of formoterol fumarate inhalation solution in patients with moderate-to-severe COPD. Int J Chron Obstruct Pulmon Dis 2019;14:117-27.
Nu-Tek. Nu-Tek Electrotherapy Machine E-Stim Pro MT1022. Accessed 4/02/21. http://www.nutekmedical.com/product/news94.html
Karashurov SE, Gudovskii LM, Semenova LI. [Electrostimulation in the therapy of bronchial asthma]. Klin Med (Mosk) 2001;79:39-41.
Aweto HA, Tella B. Awolola EO. Efficacy of interferential therapy on selected cardiopulmonary parameters, asthma control and quality of life of people living with asthma. Romanian J Physical Ther 2016;21.
Mohammed AH and Elyazed TIA. Laser puncture therapy versus interferential therapy as a combined treatment in asthmatic egyptian children: Comparison of treatment approaches. Int J Physiother Res 2017;5:2457-63.

How to Cite

Awolola Oladejo, E., & Maharaj Sooknunan, S. . (2022). Comparative efficacy of interferential therapy, bronchodilators, and body positioning on asthma control and quality of life of patients with bronchial asthma: A study protocol. Healthcare in Low-Resource Settings, 10(1). https://doi.org/10.4081/hls.2022.10251